Neuren Pharmaceuticals | NEU - Ebitda


Neuren Pharmaceuticals reported AUD11.14M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -9.69M 12.21M Dec/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Dianthus Therapeutics USD -46.46M 6.27M Mar/2026
Genetic Signatures AUD -7.11M 970K Dec/2024
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organon & Co USD 371M 44M Jun/2026
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Telix Pharmaceuticals AUD 76.49M 58.07M Jun/2026
Viatris USD 1.19B 138.8M Jun/2026
Xeris Pharmaceuticals USD 12.33M 12.76M Mar/2026